report solid result y/i organic/cc revenu growth ep
vs our/street estim compani provid encourag
profit outlook reflect anoth year strong margin expans
ep growth benefit tax reform net invest guidanc
call y/i cc revenu growth ep reflect ep
growth approxim low double-digit growth adjust net tax benefit
drag continu view attract ep maintain
outperform rate rais price target
ep rose y/i vs our/street estim revenu
increas y/i organic/cc vs estim realiz
strong ebitda margin expans led gf expans
exceed estim
wholesal growth organ off-set softer bank payment revenu
organ reflect soft apac emea if grew strong
y/i organic/cc reflect banking/wealth growth payment
provid encourag profit outlook anticip organ
revenu growth ebitda margin y/i includ
respect benefit divestitur
midpoint ep outlook would approxim exclud net tax benefit
drag vs prior estim suspect adjust consensu
rais ep estim introduc
ep estim assum report revenu declin
organic/cc ebitda margin expans
ep assum y/i organic/cc revenu growth ebitda margin
expans ep growth
believ if growth/profit remain solid gf profit profil
continu impress benefit sungard improv busi mix
overal demand environ appear direct stabl deal/pipelin
activ remain solid view attract ep
maintain outperform rate rais pt
technolog solut process servic
information-bas product servic
institut countri three
report busi segment integr
corporate/oth
analyst certif import disclosur see disclosur appendix
solid busi model high recur revenu
long-term contract solid cash flow benefit
perhap ep accret sungard data
acquisit anniversari anticip realiz
low-double-digit ep growth ex tax reform next
year benefit mid-single-digit organ revenu growth
healthi margin leverag includ sungard cost synergi
capit deploy valuat remain peer
provid favor risk/reward profil view outperform-
rate price target
usd stabil current level currenc headwind turn
sungard cost synergi continu drive strong gf margin
organ growth acceler stronger profit profil
sungard acquisit deliv annual cost synergi excess
and/or revenu synergi realiz
deal pipelin grow faster anticip pace new
ev/ebitda discount narrow close
project delay postpon impact strong recent deal
usd strengthen present increment currenc headwind
price target base price-to-earnings multipl ep ebitda
believ reason price target multipl reflect expans current ntm multipl still repres discount
primari peer
bank end-market remain uncertain could caus slowdown bank decision-mak spend furthermor bank consolid
repres risk convers rise interest rate looser regulatori environ prove benefici bank profit ultim spend
face fx risk intern oper revenu fx repres modest tailwind estim revenu growth
modestli better expect neutral fx impact
report solid result provid encourag profit outlook view
revenu just-report quarter grew organ fell expect
ebitda margin ep surpass expect adjust ep rose year/year
vs our/street estim benefit y/i ebitda margin expans
exceed estim gf margin handili beat expect if margin
expand y/i vs estim gf margin widen y/
vs estim reflect optic benefit capco divestitur busi
mix like sungard cost synergi if grew healthi organ gf grew
organ reflect solid institut wholesal growth organ off-set softer bank
 payment growth organ guidanc call y/i constant-curr
organ revenu growth ebitda margin impli ebitda midpoint despit
drag restat ep increas
competit deal environ appear broadli stabl macro bank spend
environ manag suggest seen discern pickup bank spend despit
favor interest rate regulatori tax environ said remain confid sale
momentum pipelin anticip bank spend growth approxim trade
revis ep ev/ebitda continu view highli attract
accordingli maintain outperform rate rais price target
guidanc introduc guidanc call y/i organic/cc revenu growth
nomin fx impact ebitda margin y/i ep
ebitda margin expans includ benefit benefit
divestitur lower margin busi ep guid reflect benefit tax reform off-set
increment invest spend adjust also drag ep base
lower appl appl basi exclud tax reform benefit relat invest
drag manag suggest ep guid would approxim vs prior
estim perhap low double-digit growth segment basi anticip organ if
growth organ gf growth drag if boost gf growth
respect expect tax rate lower consist
think outlook ex tax reform appear consist prior three-year
guidanc paramet call organ revenu ep growth
integr financi solut revenu revenu increas organ
bank wealth healthi y/i payment growth improv meaning
increas y/i driven fraud solut larg data analyt deal corpor digit
segment revenu growth flattish due difficult y/i licens compar anticip
rel stabl if growth segment face growth headwind
account standard revenu contract custom account chang
global financi solut revenu revenu increas organ driven solid
institut wholesal growth organ bank payment organ
growth north america temper soft result apac emea gf ebitda margin
expand y/i quarter benefit least optic recent capco
divestitur well busi mix consider suspect margin continu benefit
sungard cost synergi year gf ebitda margin expand y/i
estimates/model adjust rais ep estim introduc
estim ep assum y/i report revenu declin organic/
cc ebitda margin expans ep growth ep assum
organic/cc revenu growth ebitda margin expans impli
exhibit oper result comparison estim
million fye dec
revenu
provis incom tax
equiti earnings/minor interest
expens analysi sale
revenu
compani report oppenheim estim
million fye dec
compani report oppenheim estim
